Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senicapoc in atopic asthma with allergen challenge
2008-004152-71Phase 2Completed
- Sponsor
- Icagen
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Senicapoc with Placebo (2 arms). Primary endpoint: Late asthmatic response to allergen challenge. Started Jul 2008; status: completed.
02
Drugs
senicapoc
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-004152-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004152-71.